SLGL insider plans sale of 713 ordinary shares

SLGL security holder Itzik Yosef filed a Form 144 notice to sell 713 ordinary shares.

Accepted by SEC EDGAR 01/15/2026 - 06:54 AM EST Learn about SEC filing dates

Rhea-AI Filing Summary

SLGL security holder Itzik Yosef filed a Form 144 notice to sell 713 ordinary shares. The planned sale is to be executed through Oppenheimer & Co. Inc. on or about 01/14/2026, with an aggregate market value of $44,876.22, and the shares are listed on Nasdaq. The filing states that 27,857,620 ordinary shares were outstanding.

The 713 shares were acquired on 08/02/2016 under an employee stock option plan from the issuer, with cash payment upon option exercise dated 01/15/2026. In the past three months, the same seller has reported sales of 398, 54 and 3 ordinary shares on 01/07/2026, 01/12/2026 and 01/13/2026, for gross proceeds of $19,974.27, $3,513.01 and $195.00, respectively.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the SLGL Form 144 filing disclose?

The filing discloses that Itzik Yosef plans to sell 713 ordinary shares of SLGL on or about 01/14/2026 through Oppenheimer & Co. Inc., with an aggregate market value of $44,876.22.

How many SLGL shares is the insider currently planning to sell under this Form 144?

The notice covers a planned sale of 713 ordinary shares of SLGL, with an indicated aggregate market value of $44,876.22.

How and when were the SLGL shares being sold acquired?

The 713 ordinary shares were acquired on 08/02/2016 under an employee stock options plan from the issuer, with the purchase price to be paid in cash upon exercise on 01/15/2026.

What recent SLGL share sales has the filer reported over the past three months?

Over the past three months, Itzik Yosef reported sales of 398 shares on 01/07/2026 for $19,974.27, 54 shares on 01/12/2026 for $3,513.01, and 3 shares on 01/13/2026 for $195.00.

How many SLGL shares are outstanding according to this Form 144?

The Form 144 states that there are 27,857,620 ordinary shares of SLGL outstanding.

Which exchange is referenced for the SLGL ordinary shares in this Form 144?

The Form 144 identifies the securities exchange for the ordinary shares as Nasdaq.

Who is the broker named in the SLGL Form 144 sale plan?

The planned sale of 713 SLGL ordinary shares is to be executed through Oppenheimer & Co. Inc., 85 Broad St., New York, NY 10004.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001983527
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Sol-Gel Technologies Ltd.
SEC File Number	001-38367
Address of Issuer	7 GOLDA MEIR ST. WEIZMANN SCIENCE PARK NESS ZIONA ISRAEL 7403648
Phone	97289313433
Name of Person for Whose Account the Securities are To Be Sold	Yosef Itzik
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary	Oppenheimer & Co Inc. 85 Broad St. New York NY 10004	713	44876.22	27857620	01/14/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary	08/02/2016	Employee Stock Options plan	Issuer			713	01/15/2026	Cash Upon Exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Itzik Yosef 7 Golda Meir St. WEIZMANN SCIENCE PARK Ness Ziona L3 7403650	Ordinary	01/07/2026	398	19974.27
Itzik Yosef 7 Golda Meir St. WEIZMANN SCIENCE PARK, Ness Ziona L3 7403650	Ordinary	01/12/2026	54	3513.01
Itzik Yosef 7 Golda Meir St. WEIZMANN SCIENCE PARK Ness Ziona L3 7403650	Ordinary	01/13/2026	3	195.00

144: Remarks and Signature

Remarks	Under a 10b5-1 sale plan adopted on 09/09/2024
Date of Notice	01/14/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	09/09/2024
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Itzik Yosef
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)